|
|
 |
|
Viewing report
|
|
|
|
Booming US Generic Drug Market
RNCOS E-Services Private Limited, March 2011, Pages: 60
The US is the largest pharmaceutical markets in the world. Driven by factors, such as large healthcare spending, high per-capita income, and strong investments, the pharmaceutical market in the US has been witnessing an upward surge. Despite recession, the market continued to perform in an effective manner. Generics too have enlarged their share in the overall pharmaceutical market, in terms of both revenue and prescriptions. The US generic drugs market has been growing at a fast pace on the back of factors, such as demand for cost-effective medications, patent expiration of blockbuster drugs, and the government support.
The US generics market is anticipated to grow at a CAGR of around 10% during 2010-2013, says our recent research report “Booming US Generic Drug Market”. Currently, the market is witnessing significant developments in the form of new product categories that are attracting huge investments from both public and private players. The US government has welcomed their arrivals and extended support in the form of approvals and incentives. In terms of future scenario, major pharmaceutical players are likely to spend heavily on research and development as present market is in dynamic in nature and requires innovative products. Besides, these players will be consistently reviewing patent regime as through proactive approach, they will be able to launch their drugs first.
The generics market in the US has good growth potential in various therapy segments, which have attracted investments and market revenue in recent times. In this regard, our report provides rational analysis of various factors, which will drive the generics market in the US during the forecast period.
Overall, the report covers all the important aspects of the US generics market and provides an in-depth analysis on emerging trends, such as injectable generics, anti-counterfeit coalition, and bio-generics among others. It also provides valuable information to pharmaceutical & generics companies and investors looking to enter this market. Facts and figures regarding market size, growth, share, regulatory environment, and trends in technology development have been thoroughly analyzed in the report to provide clients a comprehensive overview of the market.
Customers who bought this item also bought
Prescription Drugs - Global Strategic Business Report
Pharmaceuticals - Global Outlook
GenericHandbook - A Guide to the Generic Drug Industry in the US - 3rd Edition
Anti-Hypertensive Drugs - Global Strategic Business Report
Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
Global Generics
The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe
Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules
Key Pharma Industry Trends 2012
Generic Drug Market in Canada
|
|
|
|
